Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
1.60
Nov 20 • 3:59 PM ET Dollar change-0.14 Percentage change(-8.05%)
Aftermarket Close
1.52
Aftermarket • 7:25 PM ET Dollar change-0.08 Percentage change(-5.24%)
Index
-
Market Cap
2.96M
Enterprise Value
4.55M
Income
-30.55M
Sales
2.90M
Book/sh
76.06
Cash/sh
4.34
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
7
IPO
May 09, 2025
P/E
-
Forward P/E
-
PEG
-
P/S
1.02
P/B
0.02
P/C
0.37
P/FCF
-
EV/EBITDA
-
EV/Sales
1.57
Quick Ratio
0.83
Current Ratio
0.83
Debt/Eq
0.07
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-29.53
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
-108.46% -
Sales past 3/5Y
- -
EPS Y/Y TTM
-377.99%
Sales Y/Y TTM
-
EPS Q/Q
507.08%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
62.68%
Insider Trans
0.00%
Inst Own
3.91%
Inst Trans
-
ROA
-37.54%
ROE
-41.10%
ROIC
-21.74%
Gross Margin
96.60%
Oper. Margin
-529.89%
Profit Margin
-1053.70%
SMA20
-37.16%
SMA50
-52.87%
SMA200
-83.36%
Trades
Shs Outstand
1.85M
Shs Float
0.69M
52W High
59.70 -97.32%
52W Low
1.51 5.96%
Volatility
15.54% 13.24%
ATR (14)
0.46
RSI (14)
27.87
Beta
1.13
Rel Volume
0.01
Avg Volume
3.68M
Volume
48,672
Perf Week
-28.25%
Perf Month
-49.37%
Perf Quarter
-66.32%
Perf Half Y
-89.33%
Perf YTD
-90.24%
Perf Year
-93.33%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
1.74
Price
1.60
Change %
-8.05%
Nov-18-26 08:44AM
Nov-16-26 08:43AM
Nov-09-26 08:00AM
Oct-13-26 09:43AM
Oct-09-26 06:00PM
08:00AM Loading…
Oct-05-26 08:00AM
Sep-29-26 08:30AM
Sep-24-26 08:30AM
Aug-03-26 09:00AM
Jul-28-26 08:30AM
Jul-07-26 09:30PM
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.
Vinod MenonSungjoon Chae